These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 12603252)

  • 1. A critical discussion of the role of neuroimaging in mild cognitive impairment.
    Wolf H; Jelic V; Gertz HJ; Nordberg A; Julin P; Wahlund LO
    Acta Neurol Scand Suppl; 2003; 179():52-76. PubMed ID: 12603252
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of neuroimaging in mild cognitive impairment.
    Matsuda H
    Neuropathology; 2007 Dec; 27(6):570-7. PubMed ID: 18021379
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cerebral metabolic changes accompanying conversion of mild cognitive impairment into Alzheimer's disease: a PET follow-up study.
    Drzezga A; Lautenschlager N; Siebner H; Riemenschneider M; Willoch F; Minoshima S; Schwaiger M; Kurz A
    Eur J Nucl Med Mol Imaging; 2003 Aug; 30(8):1104-13. PubMed ID: 12764551
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MRI and CSF studies in the early diagnosis of Alzheimer's disease.
    de Leon MJ; DeSanti S; Zinkowski R; Mehta PD; Pratico D; Segal S; Clark C; Kerkman D; DeBernardis J; Li J; Lair L; Reisberg B; Tsui W; Rusinek H
    J Intern Med; 2004 Sep; 256(3):205-23. PubMed ID: 15324364
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Accurate prediction of histologically confirmed Alzheimer's disease and the differential diagnosis of dementia: the use of NINCDS-ADRDA and DSM-III-R criteria, SPECT, X-ray CT, and APO E4 medial temporal lobe dementias. The Oxford Project to Investigate Memory and Aging.
    Jobst KA; Barnetson LP; Shepstone BJ
    Int Psychogeriatr; 1997; 9 Suppl 1():191-222; discussion 247-52. PubMed ID: 9447442
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early diagnosis of Alzheimer's disease: contribution of structural neuroimaging.
    Chetelat G; Baron JC
    Neuroimage; 2003 Feb; 18(2):525-41. PubMed ID: 12595205
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Contribution of structural neuroimaging to the early diagnosis of Alzheimer's disease.
    de Leon MJ; Convit A; DeSanti S; Bobinski M; George AE; Wisniewski HM; Rusinek H; Carroll R; Saint Louis LA
    Int Psychogeriatr; 1997; 9 Suppl 1():183-90; discussion 247-52. PubMed ID: 9546819
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Imaging discrepancies between magnetic resonance imaging and brain perfusion single-photon emission computed tomography in the diagnosis of Alzheimer's disease, and verification with amyloid positron emission tomography.
    Yokoyama S; Kajiya Y; Yoshinaga T; Tani A; Hirano H
    Psychogeriatrics; 2014 Jun; 14(2):110-7. PubMed ID: 24954834
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potential neuroimaging biomarkers of pathologic brain changes in Mild Cognitive Impairment and Alzheimer's disease: a systematic review.
    Ruan Q; D'Onofrio G; Sancarlo D; Bao Z; Greco A; Yu Z
    BMC Geriatr; 2016 May; 16():104. PubMed ID: 27184250
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prediction of Progressive Mild Cognitive Impairment by Multi-Modal Neuroimaging Biomarkers.
    Xu L; Wu X; Li R; Chen K; Long Z; Zhang J; Guo X; Yao L;
    J Alzheimers Dis; 2016; 51(4):1045-56. PubMed ID: 26923024
    [TBL] [Abstract][Full Text] [Related]  

  • 11. FDG-PET for Prediction of AD Dementia in Mild Cognitive Impairment. A Review of the State of the Art with Particular Emphasis on the Comparison with Other Neuroimaging Modalities (MRI and Perfusion SPECT).
    Sanchez-Catasus CA; Stormezand GN; van Laar PJ; De Deyn PP; Sanchez MA; Dierckx RA
    Curr Alzheimer Res; 2017; 14(2):127-142. PubMed ID: 27357645
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Prediction of the development of Alzheimer disease in patients with mild cognitive impairment].
    Kume K; Hanyu H; Sato T; Hirao K; Kanetaka H; Shimizu S; Sakurai H; Iwamoto T
    Nihon Ronen Igakkai Zasshi; 2010; 47(2):147-52. PubMed ID: 20472978
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Volumetric MRI vs clinical predictors of Alzheimer disease in mild cognitive impairment.
    Fleisher AS; Sun S; Taylor C; Ward CP; Gamst AC; Petersen RC; Jack CR; Aisen PS; Thal LJ
    Neurology; 2008 Jan; 70(3):191-9. PubMed ID: 18195264
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hippocampal and entorhinal atrophy in mild cognitive impairment: prediction of Alzheimer disease.
    Devanand DP; Pradhaban G; Liu X; Khandji A; De Santi S; Segal S; Rusinek H; Pelton GH; Honig LS; Mayeux R; Stern Y; Tabert MH; de Leon MJ
    Neurology; 2007 Mar; 68(11):828-36. PubMed ID: 17353470
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Contribution of neuroimaging to the diagnosis of Alzheimer's disease and vascular dementia.
    Román G; Pascual B
    Arch Med Res; 2012 Nov; 43(8):671-6. PubMed ID: 23142262
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of neuroimaging in Alzheimer's disease, with emphasis on brain perfusion SPECT.
    Matsuda H
    J Nucl Med; 2007 Aug; 48(8):1289-300. PubMed ID: 17631544
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Contribution of neuroimaging in the diagnosis of Alzheimer's disease and other dementias.
    Scheltens P; Korf ES
    Curr Opin Neurol; 2000 Aug; 13(4):391-6. PubMed ID: 10970055
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cognitive Composites Domain Scores Related to Neuroimaging Biomarkers within Probable-Amnestic Mild Cognitive Impairment-Storage Subtype.
    Espinosa A; Alegret M; Pesini P; Valero S; Lafuente A; Buendía M; San José I; Ibarria M; Tejero MA; Giménez J; Ruiz S; Hernández I; Pujadas F; Martínez-Lage P; Munuera J; Arbizu J; Tárraga L; Hendrix SB; Ruiz A; Becker JT; Landau SM; Sotolongo-Grau O; Sarasa M; Boada M; ;
    J Alzheimers Dis; 2017; 57(2):447-459. PubMed ID: 28269787
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hippocampal formation glucose metabolism and volume losses in MCI and AD.
    De Santi S; de Leon MJ; Rusinek H; Convit A; Tarshish CY; Roche A; Tsui WH; Kandil E; Boppana M; Daisley K; Wang GJ; Schlyer D; Fowler J
    Neurobiol Aging; 2001; 22(4):529-39. PubMed ID: 11445252
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prediction of individual clinical outcome in MCI by means of genetic assessment and (18)F-FDG PET.
    Drzezga A; Grimmer T; Riemenschneider M; Lautenschlager N; Siebner H; Alexopoulus P; Minoshima S; Schwaiger M; Kurz A
    J Nucl Med; 2005 Oct; 46(10):1625-32. PubMed ID: 16204712
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.